T0	Limitation 30805 30812	Whether
T1	Limitation 30691 30693	It
T2	Population 30720 30751	appropriate patient populations
T3	RelevantOutcomeExcluded 30756 30772	outcome measures
T4	VerySpecificPopulation 30869 30913	another subgroup of allergic asthma patients
T5	ExperimentalPhaseDuration 30925 30959	a treatment period beyond 36Â weeks
